Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Option Activities of Long-Term Incentive and Option Plans

The following information relates to our long-term incentive plans:

	December 31, 2021
	2016 Plan		2008 Plan
Maximum number of securities for issuance		5,750,000
Number of awards available to be granted (1)		2,800,002
Number of unvested restricted stock/performance-based    restricted stock/restricted stock units outstanding		1,900,986		—
Number of options outstanding		—		13,000
Number of options exercisable		—		13,000

.

(1) Includes 2008 and 2016 Plan shares canceled, forfeited, expired unexercised, which became available for reissuance under the 2016 Plan.

A summary of stock option activity in 2021 is presented below:

	2021
	Shares			Weighted-Average Exercise Price
Outstanding at beginning of year		158,600		$	26.04
Granted		—		$	—
Exercised		—		$	—
Forfeited or expired		(145,600	)	$	26.07
Outstanding at end of year		13,000		$	25.66
Exercisable at end of year		13,000		$	25.66

	2021		2020			2019
Stock-based compensation expense - Cost of sales	$	—	$	106,000		$	122,000
Stock-based compensation expense - SG&A	$	—	$	42,000		$	50,000
Income tax benefit	$	—	$	(36,000	)	$	(42,000	)
Total intrinsic value of options exercised during the year	$	—	$	—		$	—
Total fair value of options vested during the year	$	—	$	—		$	—
Total intrinsic value of options outstanding at end of year	$	—	$	—		$	—
Total intrinsic value of options exercisable at end of year	$	—	$	—		$	—
Total weighted-average remaining vesting period in years		—		—			0.49
Total weighted-average remaining contractual life period in years (options outstanding)		2.92		2.64			3.61
Total weighted-average remaining contractual life period in years (options exercisable)		2.92		2.64			3.47

Summary of Restricted Stock Activity

A summary of restricted stock activity during 2021 is presented below:

	Restricted Stock					Performance-Based Restricted Stock					Restricted Stock Units
	Shares			Weighted- Average Grant Date Fair Value		Shares			Weighted- Average Grant Date Fair Value		Shares			Weighted- Average Grant Date Fair Value
Unvested outstanding beginning of year		445,472		$	3.48		686,005		$	3.77		388,908		$	1.62
Granted		799,500		$	3.55		675,532		$	3.09		327,188		$	5.05
Vested		(295,993	)	$	3.20		(598,536	)	$	4.66		(490,866	)	$	2.34
Cancelled or forfeited		—		$	—		(20,737	)	$	4.89		(15,487	)	$	5.04
Unvested outstanding end of year		948,979		$	2.78		742,264		$	2.67		209,743		$	5.04

11.  Stockholders’ Equity (continued)

	Restricted Stock
	2021			2020			2019
Shares of restricted stock granted		799,500			40,479			371,743
Total fair value of restricted stock granted	$	2,183,000		$	87,000		$	1,223,000
Weighted-average fair value per restricted stock granted during year	$	3.55		$	2.15		$	3.29
Stock-based compensation expense - Cost of sales	$	107,000		$	62,000		$	255,000
Stock-based compensation expense - SG&A	$	1,645,000		$	1,078,000		$	1,263,000
Income tax benefit	$	(430,000	)	$	(279,000	)	$	(374,000	)
Total weighted-average remaining vesting period in years	1.84			1.61				2.18
Total fair value of restricted stock vested during the year	$	2,729,000		$	578,000		$	1,917,000

	Performance-Based Restricted Stock
	2021 (1)			2020 (1)			2019 (1)
Shares of PBRS granted		675,532			398,134			287,871
Total fair value of PBRS granted	$	2,480,000		$	980,000		$	1,608,000
Weighted-average fair value per PBRS granted during year	$	3.09		$	2.46		$	5.59
Stock-based compensation expense - Cost of sales	$	103,000		$	—		$	53,000
Stock-based compensation expense - SG&A	$	2,938,000		$	218,000		$	290,000
Income tax benefit	$	(747,000	)	$	(53,000	)	$	(84,000	)
Total weighted-average remaining vesting period in years		1.56			1.57			1.85
Total fair value of PBRS vested during the year	$	6,671,000		$	—		$	—

	Restricted Stock Units
	2021			2020			2019
Shares of RSU granted		327,188			301,361			41,383
Total fair value of RSU granted	$	1,653,000		$	255,000		$	187,000
Weighted-average fair value per RSU granted during year	$	5.05		$	0.85		$	4.53
Stock-based compensation expense - Cost of sales	$	161,000		$	—		$	53,000
Stock-based compensation expense - SG&A	$	562,000		$	255,000		$	187,000
Income tax benefit	$	(178,000	)	$	(63,000	)	$	(46,000	)
Total weighted-average remaining vesting period in years		2.42			0.48			1.57
Total fair value of RSU vested during the year	$	2,209,000		$	16,000		$	41,000

(1) Upon the CoC event associated with the Exchange Transaction during 2021, such PBRS is subject only to the time-based vesting conditions set forth in the applicable award agreement and the 2016 Plan.